Tracon Pharmaceuticals, Inc.
TCONDelisted Jul 19, 2024- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001394319
Tracon Pharmaceuticals, Inc. was delisted on Jul 19, 2024; its insiders filed their last Form 4 on Mar 13, 2024; 29 institutions reported holding it in 13F filings for Q1 2024, worth $1.39M in total; no superinvestor held it.
13F holders, Q4 2022
Institutional positions in Tracon Pharmaceuticals, Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 32
- +1 vs. Q3 2022
- Shares held
- 9.82M
- +36.9K (+0.4%) vs. Q3 2022
- Total value
- $14.6M
- −$1.70M (−10.4%) vs. Q3 2022
- New holders
- 7
- 5 more added
- Sold out
- 6
- 7 more reduced
2 institutions that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TCON on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 29 | $1.39M |
| Q4 2023 | 24 | $903.4K |
| Q3 2023 | 21 | $1.66M |
| Q2 2023 | 27 | $2.90M |
| Q1 2023 | 32 | $18.8M |
| Q4 2022 | 32 | $14.6M |
| Q3 2022 | 33 | $16.5M |
| Q2 2022 | 31 | $19.7M |
| Q1 2022 | 35 | $24.0M |
| Q4 2021 | 35 | $25.4M |
| Q3 2021 | 45 | $39.6M |
| Q2 2021 | 44 | $58.5M |
| Q1 2021 | 42 | $72.8M |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Tracon Pharmaceuticals, Inc.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Morgan Stanley | 7 | $10 | 0.00% | +7 | New |
| Bank of America Corp | 46 | $68 | 0.00% | +46 | New |
| ICA Group Wealth Management, LLC | 100 | $168 | 0.00% | +100 | New |
| Wells Fargo & Company | 217 | $323 | 0.00% | −693−76.2% | Reduced |
| TCI Wealth Advisors, Inc. | 300 | $447 | 0.00% | 00.0% | Unchanged |
| Group One Trading, L.P. | 311 | $463 | 0.00% | −3,289−91.4% | Reduced |
| Truvestments Capital LLC | 318 | $474 | 0.00% | 00.0% | Unchanged |
| Cutler Group LP | 1,200 | $1.00K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 742 | $1.11K | 0.00% | −136−15.5% | Reduced |
| Citadel Advisors LLC | 1,592 | $2.37K | 0.00% | −19,226−92.4% | Reduced |
| Advisory Services Network, LLC | 2,000 | $2.98K | 0.00% | +2,000 | New |
| Tower Research Capital LLC (TRC) | 8,517 | $13.0K | 0.00% | +1,680+24.6% | Added |
| Coastal Bridge Advisors, LLC | 10,000 | $14.9K | 0.00% | +10,000 | New |
| We Are One Seven, LLC | 11,780 | $17.6K | 0.00% | 00.0% | Unchanged |
| Hoylecohen, LLC | 13,000 | $19.4K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 17,337 | $25.8K | 0.00% | 00.0% | Unchanged |
| X-Square Capital, LLC | 17,973 | $27.0K | 0.02% | 00.0% | Unchanged |
| Virtu Financial LLC | 45,279 | $67.0K | 0.01% | +45,279 | New |
| Two Sigma Advisers, LP | 53,200 | $79.3K | 0.00% | −47,500−47.2% | Reduced |
| CI Private Wealth, LLC | 57,455 | $85.6K | 0.00% | +57,455 | New |
| Bank of New York Mellon Corp | 66,606 | $99.2K | 0.00% | −440−0.7% | Reduced |
| State Street Corp | 75,154 | $112.0K | 0.00% | 00.0% | Unchanged |
| Johnson & Johnson | 84,003 | $125.0K | 0.04% | 00.0% | Unchanged |
| Telemetry Investments, L.L.C. | 97,000 | $145.0K | 0.34% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 135,049 | $201.0K | 0.00% | +67,149+98.9% | Added |
| Geode Capital Management, LLC | 155,826 | $232.0K | 0.00% | −332−0.2% | Reduced |
| Boothbay Fund Management, LLC | 258,844 | $385.7K | 0.01% | 00.0% | Unchanged |
| BlackRock Inc. | 307,954 | $458.9K | 0.00% | +3,866+1.3% | Added |
| Linden Advisors LP | 454,916 | $677.8K | 0.01% | 00.0% | Unchanged |
| Vanguard Group Inc | 591,020 | $880.6K | 0.00% | +332+0.1% | Added |
| Ikarian Capital, LLC | 2,765,530 | $4.12M | 1.71% | 00.0% | Unchanged |
| Opaleye Management Inc. | 4,590,000 | $6.84M | 2.38% | +400,000+9.5% | Added |
| NEA Management Company, LLC | 0 | $0 | 0.00% | −346,719−100.0% | Sold out |
| CSS LLC | 0 | $0 | 0.00% | −45,219−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −40,179−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −34,390−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −12,919−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −22−100.0% | Sold out |
| Dowling & Yahnke LLC | – | – | – | – | Not filed |
| ACT Capital Management, LLC | – | – | – | – | Not filed |